- Tilray Brands reported an adjusted EBITDA of $9.33 million for the first quarter, which is an 18% decrease year-over-year. Analysts expected $13.8 million.
- Net revenue for the quarter was $200.0 million, an increase of 13% from the previous year, but below the estimate of $219.2 million.
- Cannabis revenue came in at $61.2 million, a 13% decline year-over-year, missing the estimate of $74.4 million.
- Distribution revenue slightly decreased by 1.6% year-over-year to $68.1 million, narrowly missing the estimate of $68.9 million.
- Beverage Alcohol revenue saw significant growth to $56.0 million, surpassing the previous year’s figure of $24.2 million, though below the estimate of $64.5 million.
- Wellness revenue increased by 11% year-over-year to $14.8 million, exceeding the estimated $14.1 million.
- The company reported a loss of 4.0 cents per share, an improvement from the previous year’s loss of 10 cents per share, and better than the estimated loss of 5.5 cents per share.
- Cash and cash equivalents stood at $205.2 million, a 16% increase year-over-year, surpassing the estimate of $187.3 million.
- Comments from Mr. Simon suggest optimism around potential regulatory changes in the U.S. cannabis industry following the upcoming Presidential elections.
- Analyst ratings include 3 buy recommendations, 11 holds, and no sell recommendations.
“`
A look at Tilray Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Tilray Inc‘s outlook using their Smart Scores, which provide a snapshot of various factors impacting the company’s future performance. With top scores in Value and Growth, Tilray Inc seems well-positioned for long-term success in the pharmaceutical industry. The company’s strong value score signifies that it is potentially undervalued in the market, presenting an attractive opportunity for investors. Additionally, its high growth score suggests promising prospects for expansion and revenue increase in the coming years.
Although Tilray Inc‘s Dividend score is lower, indicating a lower propensity for offering dividends to shareholders, its overall outlook remains positive due to its resilience and momentum scores. Despite facing some challenges, Tilray Inc demonstrates a moderate level of resilience to navigate through uncertainties. Moreover, a solid momentum score implies positive market sentiment and potential for upward movement in the stock price. With a diversified product portfolio in cannabis-based medicines and a global client base, Tilray Inc appears poised for continued growth and success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
